M
Michel Vidaud
Researcher at Paris Descartes University
Publications - 101
Citations - 5633
Michel Vidaud is an academic researcher from Paris Descartes University. The author has contributed to research in topics: Gene & Neurofibromatosis. The author has an hindex of 36, co-authored 101 publications receiving 5136 citations. Previous affiliations of Michel Vidaud include Institut Gustave Roussy & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL, an Antisense Noncoding RNA Whose Expression Coclusters with ARF
TL;DR: A new large antisense noncoding RNA (named ANRIL) is identified within the 403-kb germ-line deletion of the p15/CDKN2B-p16/CD KN2A-p14/ARF locus putatively involved in melanoma-NST syndrome families and in melanomas-prone families with no identified p16/ CDKN2A mutations as well as in somatic tumors.
Journal ArticleDOI
Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid.
Patrick Hohlfeld,Fernand Daffos,Jean-Marc Costa,Philippe Thulliez,François Forestier,Michel Vidaud +5 more
TL;DR: An approach based on a polymerase-chain-reaction (PCR) test performed on amniotic fluid is rapid, safe, and accurate for the prenatal diagnosis of congenital T. gondii infection.
Journal ArticleDOI
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies
Thomas De Raedt,Eline Beert,Eric Pasmant,Armelle Luscan,Hilde Brems,Nicolas Ortonne,Kristian Helin,Jason L. Hornick,Victor F. Mautner,Hildegard Kehrer-Sawatzki,Wade Clapp,James E. Bradner,Michel Vidaud,Meena Upadhyaya,Eric Legius,Karen Cichowski +15 more
TL;DR: Genomic, cellular, and mouse modelling data are provided demonstrating that the polycomb group gene SUZ12 functions as tumour suppressor in PNS tumours, high-grade gliomas and melanomas by cooperating with mutations in NF1 and it is shown that SUZ 12 loss potentiates the effects of NF1 mutations by amplifying Ras-driven transcription through effects on chromatin.
Journal ArticleDOI
Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.
Philippe Mathurin,Joseph Moussalli,Jean-François Cadranel,Vincent Thibault,Frédéric Charlotte,Patrice Dumouchel,A. Cazier,Jean-Marie Huraux,Bruno Devergie,Michel Vidaud,Pierre Opolon,Thierry Poynard +11 more
TL;DR: H hepatitis C virus patients with normal ALT showed weaker histological activity and lower fibrosis scores, and the progression rate of fibrosis was twice as slow as in HCV patients with elevated ALT, which was associated with high alcohol consumption.
Journal ArticleDOI
NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype†
Eric Pasmant,Audrey Sabbagh,Gillian Spurlock,Ingrid Laurendeau,Elisa Grillo,Marie-José Hamel,Ludovic Martin,Sébastien Barbarot,B. Leheup,Diana Rodriguez,Didier Lacombe,Hélène Dollfus,Laurent Pasquier,Bertrand Isidor,Salah Ferkal,Jean Soulier,Marc Sanson,Anne Dieux-Coeslier,Ivan Bièche,Béatrice Parfait,Michel Vidaud,Pierre Wolkenstein,Meena Upadhyaya,Dominique Vidaud +23 more
TL;DR: In this article, a high-resolution array comparative genomic hybridization (CGH) was used to characterize microdeletions in 70 unrelated NF1 microdeleted patients, compared to patients with intragenic truncating NF1 mutations and phenotyped in the same standardized way.